These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

969 related items for PubMed ID: 17576169

  • 1. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, Ishii M.
    J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
    [Abstract] [Full Text] [Related]

  • 2. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 3. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.
    Ishii M, Iwai K, Koike M, Ohshima S, Kudo-Tanaka E, Ishii T, Mima T, Katada Y, Miyatake K, Uchiyama Y, Saeki Y.
    J Bone Miner Res; 2006 Jun; 21(6):965-76. PubMed ID: 16753027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG, Sugiyama E, Shinoda K, Taki H, Hounoki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Ogawa H, Miyahara T.
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.
    Biochem Biophys Res Commun; 2005 Apr 15; 329(3):839-45. PubMed ID: 15752732
    [Abstract] [Full Text] [Related]

  • 8. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 15; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 9. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration.
    Ishida N, Hayashi K, Hattori A, Yogo K, Kimura T, Takeya T.
    J Bone Miner Res; 2006 Jan 15; 21(1):48-57. PubMed ID: 16355273
    [Abstract] [Full Text] [Related]

  • 10. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR.
    Gene; 2009 Oct 15; 446(2):90-8. PubMed ID: 19563866
    [Abstract] [Full Text] [Related]

  • 11. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 15; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

  • 12. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y.
    Eur J Immunol; 2008 Jun 15; 38(6):1598-609. PubMed ID: 18421790
    [Abstract] [Full Text] [Related]

  • 13. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 15; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 14. RANKL-induced schlafen2 is a positive regulator of osteoclastogenesis.
    Lee NK, Choi HK, Yoo HJ, Shin J, Lee SY.
    Cell Signal; 2008 Dec 15; 20(12):2302-8. PubMed ID: 18796328
    [Abstract] [Full Text] [Related]

  • 15. Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway.
    Pereverzev A, Komarova SV, Korcok J, Armstrong S, Tremblay GB, Dixon SJ, Sims SM.
    Bone; 2008 Jan 15; 42(1):150-61. PubMed ID: 17964236
    [Abstract] [Full Text] [Related]

  • 16. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B, Itzstein C, Delmas PD, Chenu C.
    J Cell Biochem; 2003 Oct 01; 90(2):424-36. PubMed ID: 14505357
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.
    J Bone Miner Res; 2011 Mar 01; 26(3):644-56. PubMed ID: 20814972
    [Abstract] [Full Text] [Related]

  • 19. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
    Egusa H, Doi M, Saeki M, Fukuyasu S, Akashi Y, Yokota Y, Yatani H, Kamisaki Y.
    Bone; 2011 Aug 01; 49(2):264-74. PubMed ID: 21504804
    [Abstract] [Full Text] [Related]

  • 20. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9176-83. PubMed ID: 18823786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.